NCT06394973: Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients with Open-angle Glaucoma or Ocular Hypertension |
|
|
| Active, not recruiting | 2 | 126 | US | T4090 0.2%, T4090 0.3%, Rhopressa® | Laboratoires Thea | Glaucoma, Ocular Hypertension | 05/25 | 05/25 | | |